GL1X · GenesisL1 explorer

Research workbench

Irak-4 inhibitors (part II)- a structure based assessment of IMIDAZO[1,2 A]PYRIDINE binding

Analyse Irak-4 inhibitors (part II)- a structure based assessment of IMIDAZO[1,2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3CGO
Type
protein
Length
332 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 10
EC
2.7.11.24
UniProt
P53779
Ligands
JNO
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 10 (EC 2.7.11.24)protein33238% helix, 17% strandP53779

Ligands and binding sites

  • JNO · 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15280.700.8046JNO
2520.270.7417empty

Compared structures

  • 3CGO · IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine… · the same entry in another collection · chain A against A, TM-score 1.00
  • P53779 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 10 (P53779) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.